DR. CHARLES HU OF INCANDO THERAPEUTICS EMCEES OPENING CEREMONY BIOHK 2022
Incando Co-Founder Organizes and Moderates International 4-Day Biotech Convention in Hong Kong
Dr. Charles Hu, cofounder of Incando Therapeutics, recently had the honor of serving as vice president of BIOHK2022, where he also moderated keynote lectures, and spoke as panelist in several roundtable discussions on entrepreneurship, investments, and talent development. BIOHK2022 is an international biotechnology convention featuring a prestigious cast of industry and academic stars from Hong Kong and abroad. The conference celebrates Hong Kong’s role as an emerging Asian biotech hub, and Incando Therapeutics is proud to have a strong presence in Hong Kong including our research collaboration with City University of Hong Kong.
Dr. Hu also presented on Incando’s recent progress on our DeepLight™ therapy for glioblastoma, as well as early preclinical work in a pipeline indication for Parkinson’s Disease neurodegeneration. The talk was presented to a packed conference session in the main theater, and was well-received.
We congratulate our friend and colleague, Dr. Charles Hu, on organizing and facilitated a successful industry event! We can’t wait for BIOHK2023, next year.
Incando Therapeutics 